Search Results - "Walker, Zuzana"

Lewy body dementias by Walker, Zuzana, Dr, Possin, Katherine L, PhD, Boeve, Bradley F, MD, Aarsland, Dag, MD

“…Summary The broad importance of dementia is undisputed, with Alzheimer's disease justifiably getting the most attention. However, dementia with Lewy bodies and…”
Get full text

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study by Kazmi, Hiba, Walker, Zuzana, Booij, Jan, Khan, Faraan, Shah, Sachit, Sudre, Carole H, Buckman, Joshua E.J., Schrag, Anette-Eleonore

“…BackgroundLate onset depression (LOD) may precede the diagnosis of Parkinson’s disease (PD) or dementia with Lewy bodies (DLB). We aimed to determine the rate…”
Get full text

Clinical utility of FDG-PET for the clinical diagnosis in MCI by Arbizu, Javier, Festari, Cristina, Altomare, Daniele, Walker, Zuzana, Bouwman, Femke, Rivolta, Jasmine, Orini, Stefania, Barthel, Henryk, Agosta, Federica, Drzezga, Alexander, Nestor, Peter, Boccardi, Marina, Frisoni, Giovanni Battista, Nobili, Flavio

“…Purpose We aim to report the quality of accuracy studies investigating the utility of [ 18 F]fluorodeoxyglucose (FDG)-PET in supporting the diagnosis of…”
Get full text

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine by Rodda, Joanne, Morgan, Shirlony, Walker, Zuzana

“…The study aim was to conduct a systematic review of the evidence from randomized, placebo controlled trials related to the efficacy of donepezil, rivastigmine…”
Get more information

START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia by Livingston, Gill, Barber, Julie, Rapaport, Penny, Knapp, Martin, Griffin, Mark, Romeo, Renee, King, Derek, Livingston, Debbie, Lewis-Holmes, Elanor, Mummery, Cath, Walker, Zuzana, Hoe, Juanita, Cooper, Claudia

“…Two-thirds of people with dementia live at home, receiving most care from family carers, about 40% of whom have clinically significant depression or anxiety…”
Get full text

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial by Aarsland, Dag, MD, Ballard, Clive, MD, Walker, Zuzana, MD, Bostrom, Fredrik, MD, Alves, Guido, MD, Kossakowski, Katja, BSc, Leroi, Iracema, MD, Pozo-Rodriguez, Francisco, MD, Minthon, Lennart, MD, Londos, Elisabet, MD

“…Summary Background Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms of dementia that substantially affect quality of…”
Get full text

Efficacy of lifestyle and psychosocial interventions in reducing cognitive decline in older people: Systematic review by Whitty, Emma, Mansour, Hassan, Aguirre, Elisa, Palomo, Marina, Charlesworth, Georgina, Ramjee, Serena, Poppe, Michaela, Brodaty, Henry, Kales, Helen C., Morgan-Trimmer, Sarah, Nyman, Samuel R., Lang, Iain, Walters, Kate, Petersen, Irene, Wenborn, Jennifer, Minihane, Anne -Marie, Ritchie, Karen, Huntley, Jonathan, Walker, Zuzana, Cooper, Claudia

“…[Display omitted] •We review interventions to reduce cognitive decline.•We include studies in people without dementia, aged 50+ or with cognitive…”
Get full text

The criteria used to rule out mild cognitive impairment impact dementia incidence rates in subjective cognitive decline by Whitfield, Tim, Chouliaras, Leonidas, Morrell, Rachel, Rubio, David, Radford, Darren, Marchant, Natalie L, Walker, Zuzana

“…The research criteria for subjective cognitive decline (SCD) exclude mild cognitive impairment (MCI), but do not stipulate the use of specific MCI criteria…”
Get full text

Dementia diagnostic criteria in Down syndrome by Sheehan, Rory, Sinai, Amanda, Bass, Nick, Blatchford, Pippa, Bohnen, Ingrid, Bonell, Simon, Courtenay, Ken, Hassiotis, Angela, Markar, Therese, McCarthy, Jane, Mukherji, Kamalika, Naeem, Asim, Paschos, Dimitrios, Perez-Achiaga, Natalia, Sharma, Vijaya, Thomas, David, Walker, Zuzana, Strydom, Andre

“…Objective Dementia is a common clinical presentation among older adults with Down syndrome. The presentation of dementia in Down syndrome differs compared with…”
Get full text

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia by Bouwman, Femke, Orini, Stefania, Gandolfo, Federica, Altomare, Daniele, Festari, Cristina, Agosta, Federica, Arbizu, Javier, Drzezga, Alexander, Nestor, Peter, Nobili, Flavio, Walker, Zuzana, Morbelli, Silvia, Boccardi, Marina

“…Purpose A joint effort of the European Association of Nuclear Medicine (EANM) and the European Academy of Neurology (EAN) aims at clinical guidance for the use…”
Get full text

Crop filling: A pipeline for repairing memory clinic MRI corrupted by partial brain coverage by Leal, Gonzalo Castro, Whitfield, Tim, Praharaju, Janaki, Walker, Zuzana, Oxtoby, Neil P.

“…Data-driven solutions offer great promise for improving healthcare. However, standard clinical neuroimaging data is subject to real-world imaging artefacts…”
Get full text

Clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carers: a study protocol for a parallel multicentre randomised controlled trial by Rapaport, Penny, Amador, Sarah, Adeleke, Mariam, Banerjee, Sube, Barber, Julie, Charlesworth, Georgina, Clarke, Christopher, Connell, Caroline, Espie, Colin, Gonzalez, Lina, Horsley, Rossana, Hunter, Rachael, Kyle, Simon D, Manela, Monica, Morris, Sarah, Pikett, Liam, Raczek, Malgorzata, Thornton, Emma, Walker, Zuzana, Webster, Lucy, Livingston, Gill

“…IntroductionMany people living with dementia experience sleep disturbance and there are no known effective treatments. Non-pharmacological treatment options…”
Get full text

Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress by Zis, Panagiotis, McHugh, Patrick, McQuillin, Andrew, Praticò, Domenico, Dickinson, Mark, Shende, Sima, Walker, Zuzana, Strydom, Andre

“…Lipid peroxidation may be a marker of free-radical-mediated injury associated with Alzheimer's disease (AD). We aimed to investigate whether changes in lipid…”
Get full text

Long-term clinical and cost-effectiveness of psychological intervention for family carers of people with dementia: a single-blind, randomised, controlled trial by Livingston, Gill, Prof, Barber, Julie, PhD, Rapaport, Penny, DClinPsych, Knapp, Martin, Prof, Griffin, Mark, MSc, King, Derek, PhD, Romeo, Renee, PhD, Livingston, Debbie, MChS, Mummery, Cath, PhD, Walker, Zuzana, MD, Hoe, Juanita, PhD, Cooper, Claudia, PhD

“…Summary Background Two-thirds of people with dementia live at home supported mainly by family carers. These carers frequently develop clinical depression or…”
Get full text

The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact by Collij, Lyduine E, Farrar, Gill, Valléz García, David, Bader, Ilona, Shekari, Mahnaz, Lorenzini, Luigi, Pemberton, Hugh, Altomare, Daniele, Pla, Sandra, Loor, Mery, Markiewicz, Pawel, Yaqub, Maqsood, Buckley, Christopher, Frisoni, Giovanni B, Nordberg, Agneta, Payoux, Pierre, Stephens, Andrew, Gismondi, Rossella, Visser, Pieter Jelle, Ford, Lisa, Schmidt, Mark, Birck, Cindy, Georges, Jean, Mett, Anja, Walker, Zuzana, Boada, Mercé, Drzezga, Alexander, Vandenberghe, Rik, Hanseeuw, Bernard, Jessen, Frank, Schöll, Michael, Ritchie, Craig, Lopes Alves, Isadora, Gispert, Juan Domingo, Barkhof, Frederik

“…Amyloid-β (Aβ) accumulation is considered the earliest pathological change in Alzheimer's disease (AD). The Amyloid Imaging to Prevent Alzheimer's Disease…”
Get full text

Long-term outcome of depressive pseudodementia in the elderly by Sáez-Fonseca, J Andrés, Lee, Lean, Walker, Zuzana

“…Abstract Background The term depressive pseudodementia has proved to be a popular clinical concept. Little is known about the long-term outcome of this…”
Get full text

Investigating the effects of impairment in non‐verbal communication on neuropsychiatric symptoms and quality of life of people living with dementia by Khan, Zunera, Da Silva, Miguel Vasconcelos, Nunez, Kayleigh‐Marie, Kalafatis, Chris, Nowicki, Steven, Walker, Zuzana, Testad, Ingelin, Francis, Paul, Ballard, Clive

“…Introduction People living with dementia in nursing homes have complex needs; impairments in cognition, communication, and daily function; neuropsychiatric…”
Get full text

Islington study of dementia subtypes in the community by STEVENS, TIM, LIVINGSTON, GILL, KITCHEN, GINNETTE, MANELA, MONICA, WALKER, ZUZANA, KATONA, CORNELIUS

“…Epidemiological studies of dementia subtypes have revealed widely varying distribution rates. There are almost no published community prevalence data for…”
Get full text

Analyzing large Alzheimer's disease cognitive datasets: Considerations and challenges by Bellio, Maura, Oxtoby, Neil P., Walker, Zuzana, Henley, Susie, Ribbens, Annemie, Blandford, Ann, Alexander, Daniel C., Yong, Keir X. X.

“…Recent data‐sharing initiatives of clinical and preclinical Alzheimer's disease (AD) have led to a growing number of non‐clinical researchers analyzing these…”
Get full text

Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan) by Grosset, Donald G, Tatsch, Klaus, Oertel, Wolfgang H, Tolosa, Eduardo, Bajaj, Nin, Kupsch, Andreas, O'Brien, John T, Seibyl, John, Walker, Zuzana, Sherwin, Paul, Chen, Chris, Grachev, Igor D

“…Ioflupane is an analog of cocaine that binds reversibly with high affinity to the dopamine transporter (DaT) protein, a marker for presynaptic terminals in…”
Get full text